{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:26:04Z","timestamp":1785583564061,"version":"3.56.0"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00011-021-01473-y","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T14:02:55Z","timestamp":1622815375000},"page":"877-889","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications"],"prefix":"10.1007","volume":"70","author":[{"given":"Nohora Cristina","family":"Ayola-Serrano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7389-9246","authenticated-orcid":false,"given":"Namrata","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zareena","family":"Fathah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Moustapha","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bivek","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Ammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Sah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej","family":"Elba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawan Sobhi","family":"Utt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Pecho-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso J.","family":"Rodriguez-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuldeep","family":"Dhama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadeq","family":"Quraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"key":"1473_CR1","first-page":"1","volume":"33","author":"K Dhama","year":"2020","unstructured":"Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Coronavirus disease 2019\u2013COVID-19. Clin Microbiol Rev [Internet]. 2020;33:1\u201348.","journal-title":"Clin Microbiol Rev [Internet]"},{"key":"1473_CR2","doi-asserted-by":"publisher","first-page":"102434","DOI":"10.1016\/j.jaut.2020.102434","volume":"109","author":"Y Yang","year":"2020","unstructured":"Yang Y, Peng F, Wang R, Yange M, Guan K, Jiang T, et al. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J Autoimmun. 2020;109:102434.","journal-title":"J Autoimmun"},{"key":"1473_CR3","doi-asserted-by":"publisher","first-page":"101567","DOI":"10.1016\/j.tmaid.2020.101567","volume":"33","author":"C Biscayart","year":"2020","unstructured":"Biscayart C, Angeleri P, Lloveras S, Chaves TDSS, Schlagenhauf P, Rodr\u00edguez-Morales AJ. The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers? \u2013 Interim recommendations January 2020, from the Latin-American Society for Travel Medicine (SLAMVI). Travel Med Infect Dis. 2020;33:101567.","journal-title":"Travel Med Infect Dis"},{"key":"1473_CR4","unstructured":"World Health Organization. Coronavirus disease (COVID-19) [Internet]. 2020 [cited 2020 Aug 9]. Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019"},{"key":"1473_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.22354\/in.v24i3.848","volume":"24","author":"J Mill\u00e1n-O\u00f1ate","year":"2020","unstructured":"Mill\u00e1n-O\u00f1ate J, Rodriguez-Morales AJ, Camacho-Moreno G, Mendoza-Ram\u00edrez H, Rodr\u00edguez-Sabogal IA, \u00c1lvarez-Moreno C. A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (COVID-19). Infection. 2020;24:187\u201392.","journal-title":"Infection"},{"key":"1473_CR6","unstructured":"Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19) [Internet]. StatPearls. StatPearls Publishing; 2020 [cited 2020 Aug 9]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32150360"},{"key":"1473_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/jmv.25709","volume":"92","author":"J Liu","year":"2020","unstructured":"Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, et al. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J Med Virol. 2020;92:491\u20134. https:\/\/doi.org\/10.1002\/jmv.25709.","journal-title":"J Med Virol"},{"key":"1473_CR8","doi-asserted-by":"publisher","first-page":"104357","DOI":"10.1016\/j.jcv.2020.104357","volume":"127","author":"JA Siordia","year":"2020","unstructured":"Siordia JA. Epidemiology and clinical features of COVID-19: a review of current literature. J Clin Virol [Internet]. 2020;127:104357.","journal-title":"J Clin Virol [Internet]."},{"key":"1473_CR9","doi-asserted-by":"publisher","first-page":"e107890","DOI":"10.1371\/journal.pone.0107890","volume":"9","author":"H-C Lin","year":"2014","unstructured":"Lin H-C, Lin T-H, Wu M-Y, Chiu Y-C, Tang C-H, Hour M-J, et al. 5-Lipoxygenase inhibitors attenuate TNF-\u03b1-induced inflammation in human synovial fibroblasts. PLoS One [Internet]. 2014;9:e107890\u2013e107890.","journal-title":"PLoS One [Internet]"},{"key":"1473_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.pnpbp.2010.07.032","volume":"35","author":"H Manev","year":"2011","unstructured":"Manev H, Chen H, Dzitoyeva S, Manev R. Cyclooxygenases and 5-lipoxygenase in Alzheimer\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry [Internet]. 2011;35:315\u20139.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry [Internet]."},{"key":"1473_CR11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/ard.62.6.501","volume":"62","author":"J Martel-Pelletier","year":"2003","unstructured":"Martel-Pelletier J, Lajeunesse D, Reboul P, Pelletier J-P. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis [Internet]. 2003;62:501\u20139.","journal-title":"Ann Rheum Dis [Internet]."},{"key":"1473_CR12","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","volume":"116","author":"TJ Guzik","year":"2020","unstructured":"Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res [Internet]. 2020;116:1666\u201387. https:\/\/doi.org\/10.1093\/cvr\/cvaa106.","journal-title":"Cardiovasc Res [Internet]."},{"key":"1473_CR13","doi-asserted-by":"crossref","unstructured":"Nicholls JM, Poon LLM, Lee KC, Ng WF, Lai ST, Leung CY, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet (London, England) [Internet]. 2003;361:1773\u20138.","DOI":"10.1016\/S0140-6736(03)13413-7"},{"key":"1473_CR14","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","volume":"361","author":"JSM Peiris","year":"2003","unstructured":"Peiris JSM, Chu CM, Cheng VCC, Chan KS, Hung IFN, Poon LLM, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet (London, England) [Internet]. 2003;361:1767\u201372.","journal-title":"Lancet (London, England) [Internet]"},{"key":"1473_CR15","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1128\/IAI.72.8.4410-4415.2004","volume":"72","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Li J, Zhan Y, Wu L, Yu X, Zhang W, et al. Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect Immun [Internet]. 2004;72:4410\u20135.","journal-title":"Infect Immun [Internet]"},{"key":"1473_CR16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1053\/j.semdp.2019.04.006","volume":"36","author":"BT Bradley","year":"2019","unstructured":"Bradley BT, Bryan A. Emerging respiratory infections: the infectious disease pathology of SARS, MERS, pandemic influenza, and legionella. Semin Diagn Pathol [Internet]. 2019;36:152\u20139.","journal-title":"Semin Diagn Pathol [Internet]."},{"key":"1473_CR17","doi-asserted-by":"publisher","first-page":"16004","DOI":"10.1038\/nmicrobiol.2016.4","volume":"1","author":"M-L Yeung","year":"2016","unstructured":"Yeung M-L, Yao Y, Jia L, Chan JFW, Chan K-H, Cheung K-F, et al. MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2. Nat Microbiol [Internet]. 2016;1:16004.","journal-title":"Nat Microbiol [Internet]."},{"key":"1473_CR18","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.20.958272","author":"Z Su","year":"2020","unstructured":"Su Z, Wu Y. A multiscale and comparative model for receptor binding of 2019 novel coronavirus and the implication of its life cycle in host cells. bioRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.02.20.958272.","journal-title":"bioRxiv"},{"key":"1473_CR19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507\u201313.","journal-title":"Lancet"},{"key":"1473_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13054-020-02911-9","volume":"24","author":"X Li","year":"2020","unstructured":"Li X, Ma X. Acute respiratory failure in COVID-19: is it \u201ctypical\u201d ARDS? Crit Care [Internet]. 2020;24:198. https:\/\/doi.org\/10.1186\/s13054-020-02911-9.","journal-title":"Crit Care [Internet]."},{"key":"1473_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","volume":"39","author":"HK Siddiqi","year":"2020","unstructured":"Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical\u2013therapeutic staging proposal. J Hear Lung Transplant [Internet]. 2020;39:405\u20137.","journal-title":"J Hear Lung Transplant [Internet]."},{"key":"1473_CR22","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) Outbreak in China: Summary of a report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239\u201342.","journal-title":"JAMA"},{"key":"1473_CR23","doi-asserted-by":"publisher","first-page":"2000607","DOI":"10.1183\/13993003.00607-2020","volume":"55","author":"RJ Mason","year":"2020","unstructured":"Mason RJ. Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J [Internet]. 2020;55:2000607.","journal-title":"Eur Respir J [Internet]."},{"key":"1473_CR24","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1161\/CIRCRESAHA.120.317055","volume":"126","author":"A Akhmerov","year":"2020","unstructured":"Akhmerov A, Marb\u00e1n E. COVID-19 and the heart. Circ Res [Internet]. 2020;126:1443\u201355.","journal-title":"Circ Res [Internet]."},{"key":"1473_CR25","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","volume":"382","author":"B Cao","year":"2020","unstructured":"Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19. N Engl J Med [Internet]. 2020;382:1787\u201399.","journal-title":"N Engl J Med [Internet]."},{"key":"1473_CR26","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.02.072439","author":"A Blanco-Miguez","year":"2020","unstructured":"Blanco-Miguez A, Sanchez B. Release of potential pro-inflammatory peptides from SARS-CoV-2 spike glycoproteins in neutrophil-extracellular traps. bioRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.05.02.072439.","journal-title":"bioRxiv"},{"key":"1473_CR27","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.chom.2020.03.021","volume":"27","author":"EZ Ong","year":"2020","unstructured":"Ong EZ, Chan YFZ, Leong WY, Lee NMY, Kalimuddin S, Haja Mohideen SM, et al. A dynamic immune response shapes COVID-19 progression. Cell Host Microbe [Internet]. 2020;27:879\u201382.","journal-title":"Cell Host Microbe [Internet]."},{"key":"1473_CR28","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.cell.2020.04.011","volume":"181","author":"D Kim","year":"2020","unstructured":"Kim D, Lee JY, Yang JS, Kim JW, Kim VN, Chang H. The architecture of SARS-CoV-2 transcriptome. Cell [Internet]. 2020;181:914\u201321.","journal-title":"Cell [Internet]."},{"key":"1473_CR29","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.87.5.e1","author":"M Donoghue","year":"2000","unstructured":"Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139. Circ Res. 2000. https:\/\/doi.org\/10.1161\/01.res.87.5.e1.","journal-title":"Circ Res"},{"key":"1473_CR30","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/s41418-020-0530-3","volume":"27","author":"Y Shi","year":"2020","unstructured":"Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X, et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ [Internet]. 2020;27:1451\u20134.","journal-title":"Cell Death Differ [Internet]."},{"key":"1473_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/ni1181","volume":"6","author":"Y Belkaid","year":"2020","unstructured":"Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol [Internet]. 2020;6:353\u201360.","journal-title":"Nat Immunol [Internet]."},{"key":"1473_CR32","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jtho.2020.02.010","volume":"15","author":"S Tian","year":"2020","unstructured":"Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol [Internet]. 2020;15:700\u20134.","journal-title":"J Thorac Oncol [Internet]."},{"key":"1473_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13549","author":"U Wollina","year":"2020","unstructured":"Wollina U, Karada\u011f AS, Rowland-Payne C, Chiriac A, Lotti T. Cutaneous signs in COVID-19 patients: a review. Dermatol Ther. 2020. https:\/\/doi.org\/10.1111\/dth.13549.","journal-title":"Dermatol Ther"},{"key":"1473_CR34","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.wneu.2020.04.222","volume":"139","author":"C Werner","year":"2020","unstructured":"Werner C, Scullen T, Mathkour M, Zeoli T, Beighley A, Kilgore MD, et al. Neurological impact of coronavirus disease of 2019: practical considerations for the neuroscience community. World Neurosurg [Internet]. 2020;139:344\u201354.","journal-title":"World Neurosurg [Internet]."},{"key":"1473_CR35","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/j.1745-7254.2007.00578.x","volume":"28","author":"LS Chu","year":"2007","unstructured":"Chu LS, Fang SH, Zhou Y, Yu GL, Wang ML, Zhang WP, et al. Minocycline inhibits 5-lipoxygenase activation and brain inflammation after focal cerebral ischemia in rats. Acta Pharmacol Sin [Internet]. 2007;28:763\u201372.","journal-title":"Acta Pharmacol Sin [Internet]."},{"key":"1473_CR36","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1001\/jama.2020.4326","volume":"323","author":"M Arentz","year":"2020","unstructured":"Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA. 2020;323:1612\u20134.","journal-title":"JAMA"},{"key":"1473_CR37","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1681\/ASN.2020040419","volume":"31","author":"D Batlle","year":"2020","unstructured":"Batlle D, Soler MJ, Sparks MA, Hiremath S, South AM, Welling PA, et al. Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology. J Am Soc Nephrol [Internet]. 2020;31:1380\u20133.","journal-title":"J Am Soc Nephrol [Internet]."},{"key":"1473_CR38","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41577-020-0353-y","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad M, Martin JC. Author correction: pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol [Internet]. 2020;20:448.","journal-title":"Nat Rev Immunol [Internet]."},{"key":"1473_CR39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/ajh.25829","volume":"95","author":"E Terpos","year":"2020","unstructured":"Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G, Dimopoulos MA. Hematological findings and complications of COVID -19. Am J Hematol [Internet]. 2020;95:14. https:\/\/doi.org\/10.1002\/ajh.25829.","journal-title":"Am J Hematol [Internet]."},{"key":"1473_CR40","first-page":"5","volume":"253","author":"S Babapoor-Farrokhran","year":"2020","unstructured":"Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Myocardial injury and COVID-19: possible mechanisms. Life Sci [Internet]. 2020;253:5.","journal-title":"Life Sci [Internet]."},{"key":"1473_CR41","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay MZ, Poh CM, R\u00e9nia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol [Internet]. 2020;20:363\u201374.","journal-title":"Nat Rev Immunol [Internet]."},{"key":"1473_CR42","doi-asserted-by":"publisher","first-page":"6935","DOI":"10.3892\/mmr.2018.8739\/abstract","volume":"17","author":"C Liu","year":"2018","unstructured":"Liu C, Zhang X, Xiang Y, Qu X, Liu H, Liu C, et al. Role of epithelial chemokines in the pathogenesis of airway inflammation in asthma (Review). Mol Med Rep [Internet]. 2018;17:6935\u201341. https:\/\/doi.org\/10.3892\/mmr.2018.8739\/abstract.","journal-title":"Mol Med Rep [Internet]."},{"key":"1473_CR43","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3389\/fimmu.2019.01347\/full","volume":"10","author":"B Dufrusine","year":"2019","unstructured":"Dufrusine B, Di Francesco A, Oddi S, Scipioni L, Angelucci CB, D\u2019Addario C, et al. Iron-dependent trafficking of 5-lipoxygenase and impact on human macrophage activation. Front Immunol [Internet]. 2019;10:1347. https:\/\/doi.org\/10.3389\/fimmu.2019.01347\/full.","journal-title":"Front Immunol [Internet]."},{"key":"1473_CR44","doi-asserted-by":"publisher","first-page":"158702","DOI":"10.1016\/j.bbalip.2020.158702","volume":"1865","author":"R Ebert","year":"2020","unstructured":"Ebert R, Cumbana R, Lehmann C, Kutzner L, Toewe A, Ferreir\u00f3s N, et al. Long-term stimulation of toll-like receptor-2 and -4 upregulates 5-LO and 15-LO-2 expression thereby inducing a lipid mediator shift in human monocyte-derived macrophages. Biochim Biophys Acta. 2020;1865:158702.","journal-title":"Biochim Biophys Acta"},{"key":"1473_CR45","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/cvr\/cvq016","volume":"86","author":"D Poeckel","year":"2010","unstructured":"Poeckel D, Funk CD. The 5-lipoxygenase\/leukotriene pathway in preclinical models of cardiovascular disease. Cardiovasc Res [Internet]. 2010;86:243\u201353.","journal-title":"Cardiovasc Res [Internet]."},{"key":"1473_CR46","doi-asserted-by":"publisher","first-page":"e102622","DOI":"10.1371\/journal.pone.0102622","volume":"9","author":"W-F Fang","year":"2014","unstructured":"Fang W-F, Douglas IS, Wang C-C, Kao H-C, Chang Y-T, Tseng C-C, et al. 5-Lipoxygenase activating protein (FLAP) dependent leukotriene biosynthesis inhibition (MK591) attenuates lipid A endotoxin-induced inflammation. PLoS One [Internet]. 2014;9:e102622.","journal-title":"PLoS One [Internet]."},{"key":"1473_CR47","doi-asserted-by":"publisher","first-page":"236345","DOI":"10.1155\/2012\/236345","volume":"2012","author":"MK McCarthy","year":"2012","unstructured":"McCarthy MK, Weinberg JB. Eicosanoids and respiratory viral infection: coordinators of inflammation and potential therapeutic targets. Mediators Inflamm. 2012;2012:236345.","journal-title":"Mediators Inflamm"},{"key":"1473_CR48","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1155\/S1110724304310041","volume":"2004","author":"H Hedi","year":"2004","unstructured":"Hedi H, Norbert G. 5-Lipoxygenase pathway, dendritic cells, and adaptive immunity. J Biomed Biotechnol. 2004;2004:99\u2013105.","journal-title":"J Biomed Biotechnol"},{"key":"1473_CR49","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/jb\/mvu078","volume":"157","author":"T Yokomizo","year":"2015","unstructured":"Yokomizo T. Two distinct leukotriene B4 receptors, BLT1 and BLT2. J Biochem [Internet]. 2015;157:65\u201371.","journal-title":"J Biochem [Internet]."},{"key":"1473_CR50","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11926-009-0051-z","volume":"11","author":"RM Pope","year":"2009","unstructured":"Pope RM, Huang QQ. The role of toll-like receptors in rheumatoid arthritis. Curr Rheumatol Rep [Internet]. 2009;11:357\u201364. https:\/\/doi.org\/10.1007\/s11926-009-0051-z.","journal-title":"Curr Rheumatol Rep [Internet]."},{"key":"1473_CR51","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1172\/JCI43157","volume":"121","author":"EM Behrens","year":"2011","unstructured":"Behrens EM, Canna SW, Slade K, Rao S, Kreiger PA, Paessler M, et al. Repeated TLR9 stimulation results in macrophage activation syndrome: like disease in mice. J Clin Invest [Internet]. 2011;121:2264\u201377.","journal-title":"J Clin Invest [Internet]."},{"key":"1473_CR52","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/v11010073","volume":"11","author":"B Yan","year":"2019","unstructured":"Yan B, Chu H, Yang D, Sze K-H, Lai P-M, Yuan S, et al. Characterization of the lipidomic profile of human coronavirus-infected cells: implications for lipid metabolism remodeling upon coronavirus replication. Viruses [Internet]. 2019;11:73.","journal-title":"Viruses [Internet]."},{"key":"1473_CR53","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1111\/all.14364","volume":"75","author":"AK Azkur","year":"2020","unstructured":"Azkur AK, Akdis M, Azkur D, Sokolowska M, Veen W, Br\u00fcggen M, et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy [Internet]. 2020;75:1564\u201381. https:\/\/doi.org\/10.1111\/all.14364.","journal-title":"Allergy [Internet]."},{"key":"1473_CR54","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/01.ATV.0000222960.43792.ff","volume":"26","author":"CD Funk","year":"2006","unstructured":"Funk CD. Lipoxygenase pathways as mediators of early inflammatory events in atherosclerosis. Arterioscler Thromb Vasc Biol [Internet]. 2006;26:1204\u20136. https:\/\/doi.org\/10.1161\/01.ATV.0000222960.43792.ff.","journal-title":"Arterioscler Thromb Vasc Biol [Internet]."},{"key":"1473_CR55","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.4049\/jimmunol.1302982","volume":"192","author":"Z Wang","year":"2014","unstructured":"Wang Z, Filgueiras LR, Wang S, Serezani APM, Peters-Golden M, Jancar S, et al. Leukotriene B 4 enhances the generation of proinflammatory microRNAs to promote MyD88-dependent macrophage activation. J Immunol [Internet]. 2014;192:2349\u201356.","journal-title":"J Immunol [Internet]."},{"key":"1473_CR56","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2147\/JIR.S178084","volume":"11","author":"V Kumar","year":"2015","unstructured":"Kumar V. Inflammasomes: pandora\u2019s box for sepsis. J Inflamm Res [Internet]. 2015;11:477\u2013502.","journal-title":"J Inflamm Res [Internet]."},{"key":"1473_CR57","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10555-020-09889-4","volume":"39","author":"D Panigrahy","year":"2020","unstructured":"Panigrahy D, Gilligan MM, Huang S, Gartung A, Cort\u00e9s-Puch I, Sime PJ, et al. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19? Cancer Metastasis Rev [Internet]. 2020;39:337\u201340. https:\/\/doi.org\/10.1007\/s10555-020-09889-4.","journal-title":"Cancer Metastasis Rev [Internet]."},{"key":"1473_CR58","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0091-6749(99)70235-6","volume":"103","author":"SM Van Schaik","year":"1999","unstructured":"Van Schaik SM, Tristram DA, Nagpal IS, Hintz KM, Welliver RC, Welliver RC. Increased production of IFN-\u03b3 and cysteinyl leukotrienes in virus- induced wheezing. J Allergy Clin Immunol [Internet]. 1999;103:630\u20136.","journal-title":"J Allergy Clin Immunol [Internet]."},{"key":"1473_CR59","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1128\/CVI.00636-12","volume":"20","author":"RV Delia","year":"2013","unstructured":"Delia RV, Harrison K, Oyston PC, Lukaszewski RA, Clark GC. Targeting the \u201cCytokine Storm\u201d for therapeutic benefit. Clin Vaccine Immunol. 2013;20:319\u201327.","journal-title":"Clin Vaccine Immunol"},{"key":"1473_CR60","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S1734-1140(10)70306-6","volume":"62","author":"A Sala","year":"2010","unstructured":"Sala A, Folco G, Murphy RC. Transcellular biosynthesis of eicosanoids. Pharmacol Rep. 2010;62:503\u201310.","journal-title":"Pharmacol Rep"},{"key":"1473_CR61","unstructured":"Katze M, Korth M, Law GL, Nathanson N. Viral Pathogenesis - 3rd Edition [Internet]. 3rd ed. Michael Katze, Marcus Korth, G. Lynn Law, Neal Nathanson, editors. Elsevier; 2016 [cited 2020 Aug 11]. Available from: https:\/\/www.elsevier.com\/books\/viral-pathogenesis\/katze\/978-0-12-800964-2"},{"key":"1473_CR62","first-page":"1941","volume":"83","author":"I Weide","year":"1994","unstructured":"Weide I, R\u00f6misch J, Simmet T. Contact activation triggers stimulation of the monocyte 5-lipoxygenase pathway via plasmin. Blood Am Soc Hematol. 1994;83:1941\u201351.","journal-title":"Blood Am Soc Hematol"},{"key":"1473_CR63","doi-asserted-by":"crossref","unstructured":"Yang Y, Tang H. Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia [Internet]. Cell. Mol. Immunol. Chinese Soc Immunology; 2016 [cited 2020 Aug 11]. p. 432\u201342. Available from: www.nature.com\/cmi","DOI":"10.1038\/cmi.2016.1"},{"key":"1473_CR64","doi-asserted-by":"publisher","unstructured":"Guo Y, Li J, Hagstr\u00f6m E, Ny T. Beneficial and Detrimental Effects of Plasmin(ogen) during Infection and Sepsis in Mice. Chakravortty D, editor. PLoS One [Internet]. Public Library of Science; 2011 [cited 2020 Aug 11];6:e24774. Available from: https:\/\/dx.plos.org\/https:\/\/doi.org\/10.1371\/journal.pone.0024774","DOI":"10.1371\/journal.pone.0024774"},{"key":"1473_CR65","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1055\/s-0040-1710317","volume":"120","author":"F Violi","year":"2020","unstructured":"Violi F, Pastori D, Cangemi R, Pignatelli P, Loffredo L. Hypercoagulation and antithrombotic treatment in coronavirus 2019: a new challenge. Thromb Haemost [Internet]. 2020;120:949\u201356. https:\/\/doi.org\/10.1055\/s-0040-1710317.","journal-title":"Thromb Haemost [Internet]."},{"key":"1473_CR66","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1111\/jth.14849","volume":"18","author":"JM Connors","year":"2020","unstructured":"Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost [Internet]. 2020;18:1559\u201361. https:\/\/doi.org\/10.1111\/jth.14849.","journal-title":"J Thromb Haemost [Internet]."},{"key":"1473_CR67","doi-asserted-by":"publisher","unstructured":"Risitano AM, Mastellos DC, Huber-Lang M, Yancopoulou D, Garlanda C, Ciceri F, et al. Author Correction: Complement as a target in COVID-19? (Nature Reviews Immunology, (2020), 20, 6, (343\u2013344), https:\/\/doi.org\/10.1038\/s41577-020-0320-7). Nat Rev Immunol [Internet]. 2020;20:448. https:\/\/doi.org\/10.1038\/s41577-020-0331-4","DOI":"10.1038\/s41577-020-0320-7 10.1038\/s41577-020-0331-4"},{"key":"1473_CR68","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/00003246-199204000-00006","volume":"20","author":"G Zilow","year":"1992","unstructured":"Zilow G, Joka T, Obertacke U, Rother U, Kirschfink M. Generation of anaphylatoxin C3a in plasma and bronchoalveolar lavage fluid in trauma patients at risk for the adult respiratory distress syndrome. Crit Care Med [Internet]. 1992;20:468\u201373.","journal-title":"Crit Care Med [Internet]."},{"key":"1473_CR69","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","volume":"171","author":"MM Markiewski","year":"2007","unstructured":"Markiewski MM, Lambris JD. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol [Internet]. 2007;171:715\u201327.","journal-title":"Am J Pathol [Internet]."},{"key":"1473_CR70","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.immuni.2014.02.009","volume":"40","author":"CD Buckley","year":"2014","unstructured":"Buckley CD, Gilroy DW, Serhan CN. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity [Internet]. 2014;40:315\u201327.","journal-title":"Immunity [Internet]."},{"key":"1473_CR71","first-page":"514","volume":"5","author":"P Italiani","year":"2014","unstructured":"Italiani P, Boraschi D. From monocytes to M1\/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol [Internet]. 2014;5:514.","journal-title":"Front Immunol [Internet]."},{"key":"1473_CR72","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1164\/ajrccm.165.2.2104050","volume":"165","author":"M Peters-Golden","year":"2002","unstructured":"Peters-Golden M, Bailie M, Marshall T, Wilke C, Phan SH, Toews GB, et al. Protection from pulmonary fibrosis in leukotriene-deficient mice. Am J Respir Crit Care Med [Internet]. 2002;165:229\u201335. https:\/\/doi.org\/10.1164\/ajrccm.165.2.2104050.","journal-title":"Am J Respir Crit Care Med [Internet]."},{"key":"1473_CR73","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1189\/jlb.0604338","volume":"76","author":"M Collin","year":"2004","unstructured":"Collin M, Rossi A, Cuzzocrea S, Patel NSA, Di Paola R, Hadley J, et al. Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton. J Leukoc Biol [Internet]. 2004;76:961\u201370.","journal-title":"J Leukoc Biol [Internet]."},{"key":"1473_CR74","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.antiviral.2017.03.022","volume":"143","author":"T Venkataraman","year":"2017","unstructured":"Venkataraman T, Frieman MB. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antiviral Res. 2017;143:142\u201350.","journal-title":"Antiviral Res"},{"key":"1473_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41413-020-0084-5","volume":"8","author":"P Zhang","year":"2020","unstructured":"Zhang P, Li J, Liu H, Han N, Ju J, Kou Y, et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Res [Internet]. 2020;8:1\u20138. https:\/\/doi.org\/10.1038\/s41413-020-0084-5.","journal-title":"Bone Res [Internet]."},{"key":"1473_CR76","doi-asserted-by":"publisher","first-page":"F732","DOI":"10.1152\/ajprenal.00262.2018","volume":"316","author":"JR Montford","year":"2019","unstructured":"Montford JR, Bauer C, Dobrinskikh E, Hopp K, Levi M, Weiser-Evans M, et al. Inhibition of 5-lipoxygenase decreases renal fibrosis and progression of chronic kidney disease. Am J Physiol - Ren Physiol [Internet]. 2019;316:F732\u201342.","journal-title":"Am J Physiol - Ren Physiol [Internet]."},{"key":"1473_CR77","doi-asserted-by":"publisher","first-page":"e23730","DOI":"10.1371\/journal.pone.0023730","volume":"6","author":"X Zhu","year":"2011","unstructured":"Zhu X, Wang Y, Zhang H, Liu X, Chen T, Yang R, et al. Genetic variation of the human \u03b1-2-Heremans-Schmid Glycoprotein (AHSG) gene associated with the risk of SARS-CoV infection. PLoS One [Internet]. 2011;6:e23730.","journal-title":"PLoS One [Internet]."},{"key":"1473_CR78","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","volume":"1843","author":"MD Turner","year":"2014","unstructured":"Turner MD, Nedjai B, Hurst T, Pennington DJ. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta - Mol Cell Res. 2014;1843:2563\u201382.","journal-title":"Biochim Biophys Acta - Mol Cell Res."},{"key":"1473_CR79","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1111\/bph.13210","volume":"172","author":"C Abrial","year":"2015","unstructured":"Abrial C, Grassin-Delyle S, Salvator H, Brollo M, Naline E, Devillier P. 15-Lipoxygenases regulate the production of chemokines in human lung macrophages. Br J Pharmacol [Internet]. 2015;172:4319\u201330. https:\/\/doi.org\/10.1111\/bph.13210.","journal-title":"Br J Pharmacol [Internet]."},{"key":"1473_CR80","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1097\/00003246-200205000-00010","volume":"30","author":"K Tschaikowsky","year":"2002","unstructured":"Tschaikowsky K, Hedwig-Geissing M, Schiele A, Bremer F, Schywalsky M, Sch\u00fcttler J. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med [Internet]. 2002;30:1015\u201323.","journal-title":"Crit Care Med [Internet]."},{"key":"1473_CR81","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2013.05.052","volume":"154","author":"VC Tam","year":"2013","unstructured":"Tam VC, Quehenberger O, Oshansky CM, Suen R, Armando AM, Treuting PM, et al. Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation. Cell. 2013;154:213.","journal-title":"Cell"},{"key":"1473_CR82","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1172\/JCI97945","volume":"128","author":"JZ Haeggstr\u00f6m","year":"2018","unstructured":"Haeggstr\u00f6m JZ. Leukotriene biosynthetic enzymes as therapeutic targets. J Clin Invest [Internet]. 2018;128:2680\u201390.","journal-title":"J Clin Invest [Internet]."},{"key":"1473_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20143580","author":"A Jo-Watanabe","year":"2019","unstructured":"Jo-Watanabe A, Okuno T, Yokomizo T. The role of leukotrienes as potential therapeutic targets in allergic disorders. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20143580.","journal-title":"Int J Mol Sci"},{"key":"1473_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2019.03.003","author":"AK H\u00e4fner","year":"2019","unstructured":"H\u00e4fner AK, Kahnt AS, Steinhilber D. Beyond leukotriene formation\u2014the noncanonical functions of 5-lipoxygenase. Prostaglandins Other Lipid Mediat. 2019. https:\/\/doi.org\/10.1016\/j.prostaglandins.2019.03.003.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"1473_CR85","doi-asserted-by":"publisher","first-page":"e45480","DOI":"10.1371\/journal.pone.0045480","volume":"7","author":"JT O\u2019Flaherty","year":"2012","unstructured":"O\u2019Flaherty JT, Hu Y, Wooten RE, Horita DA, Samuel MP, Thomas MJ, et al. 15-Lipoxygenase metabolites of docosahexaenoic acid inhibit prostate cancer cell proliferation and survival. PLoS ONE. 2012;7:e45480.","journal-title":"PLoS ONE"},{"key":"1473_CR86","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bbalip.2014.08.012","volume":"1851","author":"O R\u00e5dmark","year":"2015","unstructured":"R\u00e5dmark O, Werz O, Steinhilber D, Samuelsson B. 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease. Biochim Biophys Acta. 2015;1851:331\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"1473_CR87","doi-asserted-by":"publisher","first-page":"C37","DOI":"10.1007\/BF01991022","volume":"36","author":"J Rask-Madsen","year":"1992","unstructured":"Rask-Madsen J, Bukhave K, Laursen LS, Lauritsen K. 5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease. Agents Actions. 1992;36:C37-46.","journal-title":"Agents Actions"},{"key":"1473_CR88","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/mi.2013.71","volume":"7","author":"KA Shirey","year":"2014","unstructured":"Shirey KA, Lai W, Pletneva LM, Karp CL, Divanovic S, Blanco JCG, et al. Role of the lipoxygenase pathway in RSV-induced alternatively activated macrophages leading to resolution of lung pathology. Mucosal Immunol Nature Publishing Group. 2014;7:549\u201357.","journal-title":"Mucosal Immunol Nature Publishing Group"},{"key":"1473_CR89","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejmech.2017.10.020","volume":"153","author":"F Bruno","year":"2018","unstructured":"Bruno F, Spaziano G, Liparulo A, Roviezzo F, Nabavi SM, Sureda A, et al. Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma. Eur J Med Chem. 2018;153:65\u201372.","journal-title":"Eur J Med Chem"},{"key":"1473_CR90","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1016\/S0002-9440(10)63592-4","volume":"163","author":"TW Geisbert","year":"2003","unstructured":"Geisbert TW, Young HA, Jahrling PB, Davis KJ, Larsen T, Kagan E, et al. Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am J Pathol. 2003;163:2371\u201382.","journal-title":"Am J Pathol"},{"key":"1473_CR91","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1164\/ajrccm.165.2.2111077b","volume":"165","author":"DC Zeldin","year":"2002","unstructured":"Zeldin DC. The 5-lipoxygenase pathway: a new therapeutic target for the treatment of pulmonary fibrosis. Am J Respir Crit Care Med. 2002;165:146\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"1473_CR92","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1089\/vim.2011.0099","volume":"25","author":"W Hu","year":"2012","unstructured":"Hu W, Yen YT, Singh S, Kao CL, Wu-Hsieh BA. SARS-CoV regulates immune function-related gene expression in human monocytic cells. Viral Immunol. 2012;25:277\u201388.","journal-title":"Viral Immunol"},{"key":"1473_CR93","unstructured":"Kumar V, Abbas A, Aster J, Robbins S. Robbins Basic Pathology - 9th Edition [Internet]. Elsevier; [cited 2020 Aug 9]. Available from: https:\/\/www.elsevier.com\/books\/robbins-basic-pathology\/kumar\/978-1-4377-1781-5"},{"key":"1473_CR94","doi-asserted-by":"crossref","unstructured":"Daniel Bouchette, Charles V. Preuss. Zileuton. xPharm Compr Pharmacol Ref [Internet]. Elsevier Inc.; 2007 [cited 2020 Aug 9]. p. 1\u20133. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448202\/","DOI":"10.1016\/B978-008055232-3.62877-6"},{"key":"1473_CR95","unstructured":"Islam1 R, Fische A. A transcriptome analysis identifies potential preventive and therapeutic 1 approaches towards COVID-19. 2 3 Rezaul Islam. Preprints [Internet]. MDPI AG; 2020 [cited 2020 Aug 9];1\u201321. Available from: www.preprints.org"},{"key":"1473_CR96","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.2042-7158.1996.tb05875.x","volume":"48","author":"KD Rainsford","year":"1996","unstructured":"Rainsford KD, Ying C, Smith F. Effects of 5\u2212lipoxygenase inhibitors on interleukin production by human synovial tissues in organ culture: comparison with interleukin\u22121\u2212synthesis inhibitors*. J Pharm Pharmacol [Internet]. 1996;48:46\u201352. https:\/\/doi.org\/10.1111\/j.2042-7158.1996.tb05875.x.","journal-title":"J Pharm Pharmacol [Internet]."},{"key":"1473_CR97","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1124\/jpet.110.166967","volume":"334","author":"JL Masferrer","year":"2010","unstructured":"Masferrer JL, Zweifel BS, Hardy M, Anderson GD, Dufield D, Cortes-Burgos L, et al. Pharmacology of PF-4191834, a novel, selective non-redox 5-lipoxygenase inhibitor effective in inflammation and pain. J Pharmacol Exp Ther [Internet]. 2010;334:294\u2013301. https:\/\/doi.org\/10.1124\/jpet.110.166967.","journal-title":"J Pharmacol Exp Ther [Internet]."},{"key":"1473_CR98","first-page":"1150","volume":"43","author":"VP Singh","year":"2006","unstructured":"Singh VP, Patil C, Kumar M, Kulkarni S. Effect of 5-lipoxygenase inhibitor against lipopolysaccharide-induced hypothermia in mice. Indian J Exp Biol. 2006;43:1150\u20135.","journal-title":"Indian J Exp Biol"},{"key":"1473_CR99","doi-asserted-by":"publisher","first-page":"H1679","DOI":"10.1152\/ajpheart.00256.2006","volume":"291","author":"J Haynes","year":"2006","unstructured":"Haynes J, Obiako B, King JA, Hester RB, Ofori-Acquah S. Activated neutrophil-mediated sickle red blood cell adhesion to lung vascular endothelium: role of phosphatidylserine-exposed sickle red blood cells. Am J Physiol Circ Physiol [Internet]. 2006;291:H1679\u201385. https:\/\/doi.org\/10.1152\/ajpheart.00256.2006.","journal-title":"Am J Physiol Circ Physiol [Internet]."},{"key":"1473_CR100","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/1529-0131(200102)45:1<86::AID-ANR89>3.0.CO;2-A","volume":"45","author":"RW McMurray","year":"2001","unstructured":"McMurray RW. Nonstandard and adjunctive medical therapies for systemic lupus erythematosus. Arthritis Care Res (Hoboken) [Internet]. 2001;45:86\u2013100.","journal-title":"Arthritis Care Res (Hoboken) [Internet]."},{"key":"1473_CR101","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1113\/jphysiol.1961.sp006745","volume":"157","author":"RH Fox","year":"1961","unstructured":"Fox RH, Goldsmith R, Kidd DJ, Lewis GP. Bradykinin as a vasodilator in man. J Physiol [Internet]. 1961;157:589\u2013602.","journal-title":"J Physiol [Internet]."},{"key":"1473_CR102","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1476-5381.1991.tb12248.x","volume":"102","author":"FJ Hock","year":"1991","unstructured":"Hock FJ, Wirth K, Albus U, Linz W, Gerhards HJ, Wiemer G, et al. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol [Internet]. 1991;102:769\u201373.","journal-title":"Br J Pharmacol [Internet]."},{"key":"1473_CR103","unstructured":"Committee for Medicinal Products for Human Use - European Medicines Agency. Firazyr, INN-Icatibant acetate [Internet]. 2008. Available from: http:\/\/www.emea.europa.eu"},{"key":"1473_CR104","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/infdis\/jiv426","volume":"213","author":"P Murugesan","year":"2015","unstructured":"Murugesan P, Jung B, Lee D, Khang G, Doods H, Wu D. Kinin B1 Receptor inhibition with BI113823 reduces inflammatory response, mitigates organ injury, and improves survival among rats with severe sepsis. J Infect Dis [Internet]. 2015;213:532\u201340. https:\/\/doi.org\/10.1093\/infdis\/jiv426.","journal-title":"J Infect Dis [Internet]."},{"key":"1473_CR105","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ejphar.2018.03.017","volume":"827","author":"FLM Ricciardolo","year":"2018","unstructured":"Ricciardolo FLM, Folkerts G, Folino A, Mognetti B. Bradykinin in asthma: Modulation of airway inflammation and remodelling. Eur J Pharmacol [Internet]. 2018;827:181\u20138.","journal-title":"Eur J Pharmacol [Internet]."},{"key":"1473_CR106","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.peptides.2013.12.009","volume":"52","author":"F Gobeil","year":"2014","unstructured":"Gobeil F, Sirois P, Regoli D. Preclinical pharmacology, metabolic stability, pharmacokinetics and toxicology of the peptidic kinin B1 receptor antagonist R-954. Peptides [Internet]. 2014;52:82\u20139.","journal-title":"Peptides [Internet]."},{"key":"1473_CR107","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/14728222.2018.1409724","volume":"22","author":"F Qadri","year":"2018","unstructured":"Qadri F, Bader M. Kinin B1 receptors as a therapeutic target for inflammation. Expert Opin Ther Targets [Internet]. 2018;22:31\u201344. https:\/\/doi.org\/10.1080\/14728222.2018.1409724.","journal-title":"Expert Opin Ther Targets [Internet]."},{"key":"1473_CR108","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bcp.2016.08.023","volume":"119","author":"U Garscha","year":"2016","unstructured":"Garscha U, Voelker S, Pace S, Gerstmeier J, Emini B, Liening S, et al. BRP-187: a potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase\/5-lipoxygenase-activating protein (FLAP) complex assembly. Biochem Pharmacol [Internet]. 2016;119:17\u201326.","journal-title":"Biochem Pharmacol [Internet]."},{"key":"1473_CR109","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1039\/C7MD00390K","volume":"9","author":"C Hu","year":"2018","unstructured":"Hu C, Ma S. Recent development of lipoxygenase inhibitors as anti-inflammatory agents. Medchemcomm [Internet]. 2018;9:212\u201325.","journal-title":"Medchemcomm [Internet]."},{"key":"1473_CR110","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.redox.2015.08.006","volume":"6","author":"R Mashima","year":"2015","unstructured":"Mashima R, Okuyama T. The role of lipoxygenases in pathophysiology; new insights and future perspectives. Redox Biol [Internet]. 2015;6:297\u2013310.","journal-title":"Redox Biol [Internet]."},{"key":"1473_CR111","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12941-020-00384-w","volume":"19","author":"AA Rabaan","year":"2020","unstructured":"Rabaan AA, Al-Ahmed SH, Sah R, Tiwari R, Yatoo MI, Patel SK, et al. SARS-CoV-2\/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic. Ann Clin Microbiol Antimicrob [Internet]. 2020;19:40.","journal-title":"Ann Clin Microbiol Antimicrob [Internet]."},{"key":"1473_CR112","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.arcmed.2020.03.004","volume":"51","author":"UN Das","year":"2020","unstructured":"Das UN. Can bioactive lipids inactivate coronavirus (COVID-19)? Arch Med Res [Internet]. 2020;51:282\u20136.","journal-title":"Arch Med Res [Internet]."},{"key":"1473_CR113","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00228-020-02941-w","volume":"76","author":"M Hoxha","year":"2020","unstructured":"Hoxha M. What about COVID-19 and arachidonic acid pathway? Eur J Clin Pharmacol [Internet]. 2020;76:1501\u20134.","journal-title":"Eur J Clin Pharmacol [Internet]."},{"key":"1473_CR114","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","volume":"80","author":"Q Ye","year":"2020","unstructured":"Ye Q, Wang B, Mao J. The pathogenesis and treatment of the \u2018Cytokine Storm\u2019\u2019 in COVID-19\u2019. J Infect [Internet]. 2020;80:607\u201313.","journal-title":"J Infect [Internet]."},{"key":"1473_CR115","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1161\/CIRCULATIONAHA.120.047549","volume":"142","author":"PP Liu","year":"2020","unstructured":"Liu PP, Blet A, Smyth D, Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation [Internet]. 2020;142:68\u201378.","journal-title":"Circulation [Internet]."},{"key":"1473_CR116","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2147\/IJGM.S51364","volume":"6","author":"V Norris","year":"2013","unstructured":"Norris V, Singh D, Boyce M, Kent S, Bentley J. Inhibition of the early asthmatic response to inhaled allergen by the 5-lipoxygenase activating protein inhibitor GSK2190915: a dose&ndash;response study. Int J Gen Med [Internet]. 2013;6:897.","journal-title":"Int J Gen Med [Internet]."},{"key":"1473_CR117","first-page":"436","volume":"8","author":"YB Joshi","year":"2015","unstructured":"Joshi YB, Pratic\u00f2 D. The 5-lipoxygenase pathway: oxidative and inflammatory contributions to the Alzheimer\u2019s disease phenotype. Front Cell Neurosci [Internet]. 2015;8:436.","journal-title":"Front Cell Neurosci [Internet]."}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-021-01473-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-021-01473-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-021-01473-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T05:03:36Z","timestamp":1627362216000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-021-01473-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,4]]},"references-count":117,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1473"],"URL":"https:\/\/doi.org\/10.1007\/s00011-021-01473-y","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,4]]},"assertion":[{"value":"15 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors report no potential conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}